Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | VRTX | BMY | GILD |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 262.18 | 297.91 | 495.62 | 58.91 | 92.31 |
| High | 262.83 | 298.48 | 496.33 | 59.73 | 92.66 |
| Low | 256.75 | 292.33 | 483.55 | 58.26 | 91.30 |
| Last | 257.91 | 295.93 | 483.96 | 58.50 | 92.11 |
| Change | -6.69 | -5.51 | -10.65 | +0.09 | -0.52 |
| % Change | -2.53% | -1.83% | -2.15% | +0.15% | -0.56% |
| Volume | 615,946 | 3,481,539 | 1,157,834 | 11,216,865 | 7,979,489 |
| 20-Day Average Volume | 873,614 | 2,265,613 | 1,151,537 | 10,630,051 | 6,809,491 |
| Previous Close | 264.60 | 301.44 | 494.61 | 58.41 | 92.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 278.99 | 315.81 | 484.00 | 54.75 | 90.59 |
| 20-Day Raw Stochastic | 0.00% | 8.07% | 35.99% | 70.66% | 48.12% |
| 20-Day Relative Strength | 40.31% | 33.35% | 50.57% | 63.97% | 59.63% |
| Weighted Alpha | +29.30 | +4.76 | +31.52 | +24.72 | +30.88 |
| Today's Opinion | 40% Buy | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Previous Opinion | 40% Buy | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.53% since 11/07/24 | -8.29% since 11/07/24 | -3.76% since 11/07/24 | +6.67% since 11/07/24 | -6.03% since 11/07/24 |
| Low | 257.17 on 11/14/24 | 292.33 on 11/14/24 | 483.55 on 11/14/24 | 53.97 on 11/08/24 | 91.29 on 11/14/24 |
| High | 286.58 on 11/11/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | -9.23% since 10/14/24 | -9.06% since 10/14/24 | -0.26% since 10/14/24 | +10.80% since 10/14/24 | +8.17% since 10/14/24 |
| Low | 257.17 on 11/14/24 | 292.33 on 11/14/24 | 463.14 on 11/01/24 | 51.31 on 10/15/24 | 84.80 on 10/15/24 |
| High | 304.39 on 10/17/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -2.18% since 08/14/24 | -8.52% since 08/14/24 | +2.57% since 08/14/24 | +20.55% since 08/14/24 | +24.09% since 08/14/24 |
| Low | 244.88 on 09/06/24 | 292.33 on 11/14/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 304.39 on 10/17/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +73.89% since 05/14/24 | -5.20% since 05/14/24 | +12.83% since 05/14/24 | +30.53% since 05/14/24 | +35.99% since 05/14/24 |
| Low | 144.73 on 05/16/24 | 292.33 on 11/14/24 | 428.62 on 05/15/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 304.39 on 10/17/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,128,376 | 162,033,952 | 127,376,408 | 118,465,824 | 115,323,600 |
| Shares Outstanding, K | 128,981 | 537,533 | 257,529 | 2,028,177 | 1,244,992 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 500,920,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -111,570,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.39 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 10/31/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/31/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.55 | 0.00 | 50.44 | 21.30 |